# The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer

> **NCT05420415** · — · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 570 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** CSTME

## Key facts

- **NCT ID:** NCT05420415
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 570 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05420415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05420415, "The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05420415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*